Has Colin Huntley, MD received payments from drug or device companies?

Yes. Drug and device makers reported $19,211 in general payments to Colin Huntley, MD across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Colin Huntley, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Colin Huntley, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Colin Huntley, MD

Otolaryngology · Philadelphia, PANPI 1881984169

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (53.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 95.6% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $15,171, more than ten times the $1,148 reported in 2019. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,211in general payments, 2019–2025

Across 86 payments — averaging $223.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Inspire Medical Systems, Inc.$18K
Fujifilm Healthcare Americas Corporation$145
GSK$131
Medrobotics Inc.$124
Stryker$110
Livanova USA, Inc.$103
plus $233 from 6 others

$155,270in research payments, 2019–2025

Across 17 payments — averaging $9133.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Inspire Medical Systems, Inc.$155K

What the payments were for

Consulting fees$10,33454%
Speaking & faculty fees$2,25012%
Travel & lodging$2,35912%
Food & beverage$4,26822%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Inspire Medical Systems, Inc.	61	$18,364
Fujifilm Healthcare Americas Corporation	2	$145
GSK	8	$131
Medrobotics Inc.	1	$124
Stryker	3	$110
Livanova USA, Inc.	1	$103
Acclarent, Inc	4	$72
ERBE USA Inc	1	$70
Optinose US, Inc.	2	$41
Lilly USA, LLC	1	$19
Merck	1	$16
Regeneron Healthcare Solutions, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Inspire$15,317
Inspire Upper Airway Stimulation System$2,128
THN Sleep Therapy$103

How this compares

$19,211 in reported general payments places this provider in the 90th percentile of 456 otolaryngology providers in Pennsylvania.

See all otolaryngology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$161,660

Medicare patients

345

Services billed

1,112

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Azelastine Hcl	282	$5,668
Doxepin Hcl	12	$2,578
Fluticasone Propionate	166	$1,935
Gabapentin	49	$1,487
Ipratropium Bromide	49	$1,362
Eszopiclone	64	$1,284
Famotidine	115	$1,141
Omeprazole	89	$1,109
Nortriptyline Hcl	34	$575
Montelukast Sodium	11	$161
Pantoprazole Sodium	18	$156
Zolpidem Tartrate	25	$137
Methylprednisolone	14	$59
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	11	$31

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Philadelphia

Nancy SnydermanPhiladelphia$4.5M
David KennedyPhiladelphia$603K
James PalmerPhiladelphia$331K
Mathew NagorskyPhiladelphia$95K
Noam CohenPhiladelphia$76K
Nithin AdappaPhiladelphia$72K
Steven CannadyPhiladelphia$33K
David CognettiPhiladelphia$30K
John KrousePhiladelphia$30K
Soo AbboudPhiladelphia$23K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →